Molecules, Volume 29, Issue 15
2024 August-1 - 272 articles
Cover Story: This review explores advancements in the application of nitro(het)aromatic bioreductive agents for hypoxic tumor environments. Their role as gene-directed enzyme prodrugs is examined. These prodrugs are inert until activated by specific tumor enzymes, consequently being transforming into potent cytotoxic agents. The review also covers recent developments regarding prodrug conjugates containing nitro(het)aromatic moieties that are activated under tumor hypoxia, enhancing treatment specificity. Additionally, the use of nitro(het)aromatic compounds as fluorescent probes for imaging hypoxic tumors is discussed, enabling a non-invasive visualization of low-oxygen regions for diagnosis, treatment planning, and monitoring therapeutic responses. We hope this review will inspire researchers to design and synthesize improved compounds for selective cancer treatment and early diagnostics. View this paper - Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
- You may sign up for email alerts to receive table of contents of newly released issues.
- PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.